T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.94B |
| 2 |
Broadcom
AVGO
|
+$2.74B |
| 3 |
Microsoft
MSFT
|
+$2.33B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.47B |
| 5 |
GE Aerospace
GE
|
+$1.27B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.42B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$2.44B |
| 3 |
Apple
AAPL
|
+$2.42B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.3B |
| 5 |
Eli Lilly
LLY
|
+$1.78B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.73% |
| 2 | Financials | 12.11% |
| 3 | Healthcare | 10.97% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Patterson-UTI
PTEN
$4.16B
| $3.28M | ﹤0.01% |
553,047
-22,481
| -4% | -$135K |
|
1427
Quaker Houghton
KWR
$2.95B
| $3.28M | ﹤0.01% |
29,275
+4,795
| +20% | +$521K |
|
|
SWTX
1428
DELISTED
SpringWorks Therapeutics
SWTX
| $3.25M | ﹤0.01% |
69,269
-2,513,463
| -97% | -$112M |
|
|
ESGR
1429
DELISTED
Enstar Group
ESGR
| $3.25M | ﹤0.01% |
9,674
+472
| +5% | +$158K |
|
1430
SiriusXM
SIRI
$9.43B
| $3.23M | ﹤0.01% |
140,617
-10,872
| -7% | -$234K |
|
1431
CRISPR Therapeutics
CRSP
$5.22B
| $3.23M | ﹤0.01% |
66,367
+39,004
| +143% | +$1.51M |
|
1432
Carriage Services
CSV
$535M
| $3.23M | ﹤0.01% |
70,545
+2,160
| +3% | +$90.2K |
|
1433
Independence Realty Trust
IRT
$3.96B
| $3.23M | ﹤0.01% |
182,314
+20,870
| +13% | +$392K |
|
1434
Avnet
AVT
$7.87B
| $3.2M | ﹤0.01% |
60,268
+1,341
| +2% | +$66.6K |
|
1435
WSFS Financial
WSFS
$4.15B
| $3.2M | ﹤0.01% |
58,143
+4,485
| +8% | +$233K |
|
1436
Texas Capital Bancshares
TCBI
$4.38B
| $3.19M | ﹤0.01% |
40,182
+2,733
| +7% | +$196K |
|
1437
NOV
NOV
$7.45B
| $3.17M | ﹤0.01% |
254,733
+11,528
| +5% | +$145K |
|
1438
Plexus
PLXS
$7.25B
| $3.17M | ﹤0.01% |
23,385
+1,847
| +9% | +$237K |
|
1439
Aura Biosciences
AURA
$802M
| $3.16M | ﹤0.01% |
504,828
-14,957
| -3% | -$87.5K |
|
1440
Metropolitan Bank Holding Corp
MCB
$1.17B
| $3.15M | ﹤0.01% |
45,026
-9,265
| -17% | -$574K |
|
1441
Renasant Corp
RNST
$4B
| $3.15M | ﹤0.01% |
87,636
+31,040
| +55% | +$1.03M |
|
1442
Otter Tail
OTTR
$3.87B
| $3.15M | ﹤0.01% |
40,802
+1,536
| +4% | +$120K |
|
1443
White Mountains Insurance
WTM
$5.06B
| $3.15M | ﹤0.01% |
1,751
+79
| +5% | +$141K |
|
1444
10x Genomics
TXG
$7.52B
| $3.14M | ﹤0.01% |
271,078
+19,814
| +8% | +$181K |
|
1445
Life Time Group Holdings
LTH
$9.9B
| $3.13M | ﹤0.01% |
103,142
+30,706
| +42% | +$911K |
|
1446
MSC Industrial Direct
MSM
$6.67B
| $3.13M | ﹤0.01% |
36,788
+566
| +2% | +$44.7K |
|
1447
FormFactor
FORM
$10.3B
| $3.13M | ﹤0.01% |
90,824
-456,893
| -83% | -$13.9M |
|
1448
nCino
NCNO
$2.26B
| $3.12M | ﹤0.01% |
111,626
+10,735
| +11% | +$268K |
|
1449
PJT Partners
PJT
$4.36B
| $3.12M | ﹤0.01% |
18,891
+1,351
| +8% | +$196K |
|
1450
Boise Cascade
BCC
$2.94B
| $3.11M | ﹤0.01% |
35,827
-253,048
| -88% | -$22.9M |
|
Similar funds
T. Rowe Price Associates's Q2 2025 Portfolio in Review
As of Q2 2025, T. Rowe Price Associates held 3,193 positions worth $883B, up 8.8% from $812B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2025 filing shows 153 new, 2,010 increased, 803 reduced and 136 closed positions. Its largest new stake was Ralliant Corp: 4,667,638 shares worth $226M. The largest sale was Amazon, an estimated $3.42B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q2 2025 buy was Ralliant Corp: 4,667,638 shares worth $226M.
- T. Rowe Price Associates added most to NVIDIA in Q2 2025, an estimated $3.94B increase.
- T. Rowe Price Associates's biggest Q2 2025 reduction was Amazon, cutting an estimated $3.42B.
- T. Rowe Price Associates fully exited US Steel in Q2 2025, selling an estimated $146M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $883B portfolio in Q2 2025.
- T. Rowe Price Associates opened 153 new positions and closed 136 in Q2 2025.
- T. Rowe Price Associates's portfolio value rose 8.8% quarter-over-quarter to $883B.
Based on T. Rowe Price Associates's 13F filing for Q2 2025, filed 14 Aug 2025.